Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.

Zhou, Yi

Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. [electronic resource] - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Feb 2012 - 237-45 p. digital

Publication Type: Journal Article

1530-0285

10.1038/modpathol.2011.158 doi


Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Clinical Trials as Topic
Cyclophosphamide--administration & dosage
Female
Humans
Incidence
Kaplan-Meier Estimate
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Male
Middle Aged
Neoplasms, Second Primary--chemically induced
Retrospective Studies
Rituximab
Vidarabine--administration & dosage